Rosalie Heilig

Rosalie Heilig

Auto-generated profile, based on publicly available information

Rosalie Heilig

Cancer Research UK Scotland Institute, Switchback Road, Glasgow, G61 1BD, UK

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2016 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
LSLorenzo Sborgi
Lorenzo Sborgi
SRSebastian Rühl
Sebastian Rühl
EMEstefania Mulvihill
Estefania Mulvihill
JPJoka Pipercevic
Joka Pipercevic
RHRosalie Heilig
Rosalie Heilig
SHSebastian Hiller
Sebastian Hiller
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

23 November 2018 in Science
Verified
Journal Article
Closed access
PDF file
SRSebastian Rühl
Sebastian Rühl
KSKateryna Shkarina
Kateryna Shkarina
BDBenjamin Demarco
Benjamin Demarco
RHRosalie Heilig
Rosalie Heilig
JSJosé Carlos Santos
José Carlos Santos
PBPetr Broz
Petr Broz
Fine-tuning pyroptosis with ESCRT-III: Pyroptosis is an inflammatory form of cell death induced by select caspases downstream of inflammasome complexes. These caspases cleave gasdermin D (GSDMD), whose N-terminal fragments quickly form large permeability pores that induce cell death. However, a large percentage of cells with active inflammasomes are resistant to pyroptosis. Rühl et al. found that the membrane-remodeling ESCRT-III machinery was recruited to the plasma membrane upon GSDMD activation. ESCRT-III–dependent membrane repair limited proinflammatory cytokine secretion and pyroptosis after activation of inflammasomes. Science , this issue p. 956

23 December 2017 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
RHRosalie Heilig
Rosalie Heilig
MDMathias S. Dick
Mathias S. Dick
LSLorenzo Sborgi
Lorenzo Sborgi
EMEtienne Meunier
Etienne Meunier
SHSebastian Hiller
Sebastian Hiller
PBPetr Broz
Petr Broz
The pro‐inflammatory cytokine IL‐1β is well known for its role in host defense and the initiation of potent inflammatory responses. It is processed from its inactive pro‐form by the inflammatory caspase‐1 into its mature bioactive form, which is then released from the cell via an unconventional secretion mechanism. Recently, gasdermin‐D has been identified as a new target of caspase‐1. After proteolytical cleavage of gasdermin‐D, the N‐terminal fragment induces pyroptosis, a lytic cell death, by forming large permeability pores in the plasma membrane. Here we show using the murine system that gasdermin‐D is required for IL‐1β secretion by macrophages, dendritic cells and partially in neutrophils, and that secretion is a cell‐lysis‐independent event. Liposome transport assays in vitro further demonstrate that gasdermin‐D pores are large enough to allow the direct release of IL‐1β. Moreover, IL‐18 and other small soluble cytosolic proteins can also be released in a lysis‐independent but gasdermin‐D‐dependent mode, suggesting that the gasdermin‐D pores allow passive the release of cytosolic proteins in a size‐dependent manner.

22 March 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
KCKaiwen W Chen
Kaiwen W Chen
BDBenjamin Demarco
Benjamin Demarco
RHRosalie Heilig
Rosalie Heilig
KSKateryna Shkarina
Kateryna Shkarina
ABAndreas Boettcher
Andreas Boettcher
PBPetr Broz
Petr Broz
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 December 2017 in Cell Reports
Verified
Journal Article
Open access
KSKatharina S. Schneider
Katharina S. Schneider
CGChristina J. Groß
Christina J. Groß
RDRoland F. Dreier
Roland F. Dreier
BSBenedikt S. Saller
Benedikt S. Saller
RMRitu Mishra
Ritu Mishra
OGOlaf Groß
Olaf Groß
Inflammasomes activate the protease caspase-1, which cleaves interleukin-1β and interleukin-18 to generate the mature cytokines and controls their secretion and a form of inflammatory cell death called pyroptosis. By generating mice expressing enzymatically inactive caspase-1C284A, we provide genetic evidence that caspase-1 protease activity is required for canonical IL-1 secretion, pyroptosis, and inflammasome-mediated immunity. In caspase-1-deficient cells, caspase-8 can be activated at the inflammasome. Using mice either lacking the pyroptosis effector gasdermin D (GSDMD) or expressing caspase-1C284A, we found that GSDMD-dependent pyroptosis prevented caspase-8 activation at the inflammasome. In the absence of GSDMD-dependent pyroptosis, the inflammasome engaged a delayed, alternative form of lytic cell death that was accompanied by the release of large amounts of mature IL-1 and contributed to host protection. Features of this cell death modality distinguished it from apoptosis, suggesting it may represent a distinct form of pro-inflammatory regulated necrosis.

6 December 2017 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
RHRosalie Heilig
Rosalie Heilig
PBPetr Broz
Petr Broz